Britain's Vectura collaborates with Janssen in asthma, COPD

LONDON, Jan 6 (Reuters) - Vectura Group, a respiratory drugs specialist, will work with Janssen Biotech to develop treatments for asthma and lung disease COPD, it said on Tuesday.